NEJM & STEM CELLS: the New England Journal of Medicine has again expressed its strong support for therapeutic cloning. The deputy editor of the prestigious journal, Dr Robert S. Schwartz, wrote in an official commentary in the current issue that " Research on stem cells will encounter many twists and turns, but it is an endeavour that is eminently worth pursuing. The delay of medical advances by theological disputes is not in the best interests of the sick and disabled."